Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Dry Eye > Tear cytokine ratios may be a potential dry eye disease biomarker
  • Dry Eye

Tear cytokine ratios may be a potential dry eye disease biomarker

Ophthalmology 360

Tear inflammatory cytokine ratios (CRs) may hold potential as a more nuanced biomarker for of dry eye disease (DED compared to absolute cytokine levels, according to a study.

Although some significant correlations were found between certain cytokine ratios and DED signs, no significant correlation was observed with DED symptoms as measured by the Ocular Surface Disease Index (OSDI).

The study emphasizes the need for further research in diverse dry eye populations, addressing potential biases in sampling and variations in tear collection techniques.

The study, conducted across 10 sites as part of the Dry Eye Assessment and Management study, included 131 patients. Tear concentrations of key cytokines (IL-1b, IL-6, IL-8, IL-10, IL-17A, IFN-g, and TNF-a) were measured, alongside various DED signs and symptoms.

Results showed that certain cytokine ratios, including IL-6:IL-10, IL-8:IL-10, and TNF-a:IL-10, exhibited significant correlations, primarily with conjunctival or corneal staining, as well as the composite sign severity score. For instance, IL-8:IL-10 and conjunctival staining demonstrated a correlation coefficient (rho) of 0.19 (P = 0.03), while IL-6:IL-10 and corneal staining showed a rho of 0.31 (P < 0.001).

Reference
Zhao CS, Chen Y, Ying GS, Asbell PA; Dry Eye Assessment and Management (DREAM) Study Group. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study. Curr Eye Res. 2023;1-9. doi: 10.1080/02713683.2023.2262168. Epub ahead of print. PMID: 37781912.

Share

Related Content

  • Dry Eye

Spotlight on VEVYE®

  • Dry Eye

Oral vitamin D boosts response to topical therapy in dry eye disease

  • Dry Eye

Dry eye in older adults linked to poorer sleep quality and reduced deep sleep

  • Contact Lenses

Soft contact lens users report cleaner, more comfortable wear with Biotrue Hydration Plus

  • Dry Eye

Probiotic use tied to lower risk of primary open-angle glaucoma in adults with dry eye

  • Ocular Surface Disease

Symptomatic MGD shows distinct age-related clinical patterns

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon